092190 — Seoul Viosys Co Balance Sheet
0.000.00%
- KR₩145bn
- KR₩545bn
- KR₩699bn
- 46
- 54
- 54
- 53
Annual balance sheet for Seoul Viosys Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,947 | 13,532 | 13,170 | 19,791 | 10,732 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 61,577 | 91,264 | 105,760 | 92,143 | 117,303 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 137,938 | 219,237 | 219,085 | 212,412 | 276,463 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 402,218 | 502,693 | 500,641 | 489,411 | 487,549 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 582,883 | 775,635 | 755,995 | 733,424 | 795,814 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 297,549 | 268,994 | 298,911 | 469,308 | 522,549 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 407,234 | 610,444 | 676,680 | 715,596 | 757,062 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 175,649 | 165,191 | 79,315 | 17,828 | 38,752 |
Total Liabilities & Shareholders' Equity | 582,883 | 775,635 | 755,995 | 733,424 | 795,814 |
Total Common Shares Outstanding |